Formulation and Assessment of Prednisolone Matrix Tablets with a Blend of Natural Polysaccharides: Colon-Specific Drug Delivery Via Wet Granulation Approach
DOI:
https://doi.org/10.52783/jns.v14.2414Keywords:
Natural polysaccharide, Prednisolone, colon targeting, matrix tablets, microfloraAbstract
This study aimed to evaluate the formulation and characterization of matrix tablets using a natural polysaccharide blend of Angelica sinensis polysaccharide and Tamarind Seed Polysaccharide (AT-P). The blend was prepared in a 1:1 ratio and assessed for its potential as a binding agent in controlled-release tablet formulations. Preformulation studies, including pH, viscosity, bulk density, tapped density, and compressibility index, were conducted to ensure compatibility and stability. Five matrix tablet formulations (TF1 to TF5) were developed using wet granulation with Prednisolone as the active pharmaceutical ingredient. The tablets were subjected to various evaluation parameters such as thickness, hardness, friability, and content uniformity, followed by in vitro release studies in both the presence and absence of rat caecal matter to simulate colonic conditions. The kinetic modeling of drug release data revealed that TF3 followed zero-order kinetics, while TF2 and TF5 exhibited strong fits to both zero-order and Higuchi models. In the presence of rat caecal matter, a significant acceleration in drug release was observed, indicating the responsiveness of the formulations to the colonic environment. The study concluded that the natural polysaccharide blend (AT-P) is a promising excipient for controlled drug delivery systems targeting the colon.
Downloads
Metrics
References
ASIAN ROCKVILLE, M. D. United States Pharmacopoeia 24/NF19. 2000.
AZEHAF, H., BENZINE, Y., TAGZIRT, M., SKIBA, M. & KARROUT, Y. 2023. Microbiota-sensitive drug delivery systems based on natural polysaccharides for colon targeting. Drug Discov Today, 28, 103606.
BANSAL, V., MALVIYA, R., MALAVIYA, T. & SHARMA, P. K. 2014. Novel prospective in colon specific drug delivery system. Polim Med, 44, 109-18.
CHADHA, S., KUMAR, A., SRIVASTAVA, S. A., BEHL, T. & RANJAN, R. 2020. Inulin as a Delivery Vehicle for Targeting Colon-Specific Cancer. Curr Drug Deliv, 17, 651-674.
CHOURASIA, M. K. & JAIN, S. K. 2004. Polysaccharides for colon targeted drug delivery. Drug Deliv, 11, 129-48.
FRIEND, D. R. & TOZER, T. N. 1992. Drug glycosides in oral colon-specific drug delivery. Journal of controlled release, 19, 109-120.
GULBAKE, A. & JAIN, S. K. 2012. Chitosan: a potential polymer for colon-specific drug delivery system. Expert Opin Drug Deliv, 9, 713-29.
HOVGAARD, L. & BRONDSTED, H. 1996. Current applications of polysaccharides in colon targeting. Critical Reviews™ in Therapeutic Drug Carrier Systems, 13.
JAIN, A., GUPTA, Y. & JAIN, S. K. 2007. Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon. J Pharm Pharm Sci, 10, 86-128.
JAIN, S. K. & JAIN, A. 2008. Target-specific drug release to the colon. Expert Opin Drug Deliv, 5, 483-98.
JAIN, S. N. & PATIL, S. B. 2023. Perspectives of colon-specific drug delivery in the management of morning symptoms of rheumatoid arthritis. Inflammopharmacology, 31, 253-264.
JUNIOR, A. G. T., DE ARAÚJO, J. T. C., DUARTE, J. L., SILVESTRE, A. L. P., DI FILIPPO, L. D. & CHORILLI, M. 2023. Polymeric Systems for Colon-specific Mesalazine Delivery in the Intestinal Bowel Diseases Management. Curr Med Chem, 30, 1351-1367.
KOTLA, N. G., GULATI, M., SINGH, S. K. & SHIVAPOOJA, A. 2014. Facts, fallacies and future of dissolution testing of polysaccharide based colon-specific drug delivery. J Control Release, 178, 55-62.
KRISHNAIAH, Y. S. R., REDDY, P. R. B., SATYANARAYANA, V. & KARTHIKEYAN, R. S. 2002. Studies on the development of oral colon targeted drug delivery systems for metronidazole in the treatment of amoebiasis. International journal of pharmaceutics, 236, 43-55.
LIEBERMAN, H., RIEGER, M. & BANKER, G. S. 2020. Pharmaceutical Dosage Forms: Disperse Systems, CRC Press.
MISHRA, M. K. & KUMARI, P. 2019. A review on pharmaceutical process validation. The Pharma Innovation Journal, 6, 960-958.
NAEEM, M., AWAN, U. A., SUBHAN, F., CAO, J., HLAING, S. P., LEE, J., IM, E., JUNG, Y. & YOO, J. W. 2020. Advances in colon-targeted nano-drug delivery systems: challenges and solutions. Arch Pharm Res, 43, 153-169.
OMAR, S., ALDOSARI, B., REFAI, H. & GOHARY, O. A. 2007. Colon-specific drug delivery for mebeverine hydrochloride. J Drug Target, 15, 691-700.
PATEL, M. & AMIN, A. 2011. Recent trends in microbially and/or enzymatically driven colon-specific drug delivery systems. Crit Rev Ther Drug Carrier Syst, 28, 489-552.
PATEL, M. M. 2015. Colon: a gateway for chronotherapeutic drug delivery systems. Expert Opin Drug Deliv, 12, 1389-95.
PEPPERCORN, M. A. & GOLDMAN, P. 1972. The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. Journal of Pharmacology and Experimental Therapeutics, 181, 555-562.
PINTO, J. F. 2010. Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon. Int J Pharm, 395, 44-52.
PRASAD, Y. V. R., KRISHNAIAH, Y. S. R. & SATYANARAYANA, S. 1998. In vitro evaluation of guar gum as a carrier for colon-specific drug delivery. Journal of controlled release, 51, 281-287.
RAO, K. P. & PATIL, C. C. 2007. Formulation and evaluation of colon targeted oral tablets of naproxen. Indian Journal of Pharmaceutical Education and Research, 41, 146-149.
ROLDO, M., BARBU, E., BROWN, J. F., LAIGHT, D. W., SMART, J. D. & TSIBOUKLIS, J. 2007. Azo compounds in colon-specific drug delivery. Expert Opin Drug Deliv, 4, 547-60.
RUBINSTEIN, A., NAKAR, D. & SINTOV, A. 1992. Chondroitin sulfate: a potential biodegradable carrier for colon-specific drug delivery. International journal of pharmaceutics, 84, 141-150.
SINHA, V., SINGH, A., KUMAR, R. V., SINGH, S., KUMRIA, R. & BHINGE, J. 2007. Oral colon-specific drug delivery of protein and peptide drugs. Crit Rev Ther Drug Carrier Syst, 24, 63-92.
SINHA, V. R. & KUMRIA, R. 2001. Polysaccharides in colon-specific drug delivery. Int J Pharm, 224, 19-38.
VAN DEN MOOTER, G. 2006. Colon drug delivery. Expert Opin Drug Deliv, 3, 111-25.
VAN DEN MOOTER, G. & KINGET, R. 1995. Oral colon-specific drug delivery: a review. Drug delivery, 2, 81-93.
VANDAMME, T. F., LENOURRY, A., CHARRUEAU, C. & CHAUMEIL, J. C. 2002. The use of polysaccharides to target drugs to the colon. Carbohydrate polymers, 48, 219-231.
WILDING, I. R., DAVIS, S. S. & O'HAGAN, D. T. 1994. Targeting of drugs and vaccines to the gut. Pharmacology & therapeutics, 62, 97-124.
YANG, L., CHU, J. S. & FIX, J. A. 2002. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm, 235, 1-15.
YASMIN, F., NAJEEB, H., SHAIKH, S., HASANAIN, M., NAEEM, U., MOEED, A., KORITALA, T., HASAN, S. & SURANI, S. 2022. Novel drug delivery systems for inflammatory bowel disease. World J Gastroenterol, 28, 1922-1933.
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.